Lanean...
FOS-like antigen 1 is a prognostic biomarker in hepatocellular carcinoma
BACKGROUND/AIM: The prognosis of hepatocellular carcinoma (HCC) is very dismal and the targeted drugs of HCC are limited. Studies of HCC prognostic biomarkers have made little progress, though many new techniques such as high-throughput sequencing have been applied. FOS-like antigen 1 (FOSL1) is gen...
Gorde:
| Argitaratua izan da: | Saudi J Gastroenterol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wolters Kluwer - Medknow
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6941458/ https://ncbi.nlm.nih.gov/pubmed/31274473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sjg.SJG_595_18 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|